Conclusion: Study indicates that machinery should be developed to characterize undetected HBV carriers in developing countries by conducting multi-center clinical studies. We have shown that considerable number of patients, unaware of their HBV infection, suffer from progressive liver damage. The overall strategy of management of chronic HBV infection should also be revisited.